Hydrogen-rich saline prevents early neurovascular dysfunction resulting from inhibition of oxidative stress in STZ-diabetic rats

Current Eye Research

Volumn 38, Issue 3, 2013, Pages 396-404

  Feng, Yanqing ^a   Wang, Ruobing ^b   Xu, Jiajun ^c   Sun, Jingchuan ^c   Xu, Tao ^c   Gu, Qing ^b   Wu, Xingwei ^b  

^a Shanghai Kongjiang Hospital   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Diabetic retinopathy; Hydrogen; Oscillatory potentials; Oxidative stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN; HYDROGEN RICH SALINE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; MALE; NEUROLOGIC DISEASE; NEUROVASCULAR DYSFUNCTION; NITROSATIVE STRESS; NONHUMAN; OSCILLATORY POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RETINA CELL; STREPTOZOCIN DIABETES; SYNAPSE VESICLE; VISION;

ALDEHYDES; ANIMALS; BLOOD GLUCOSE; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL NEOVASCULARIZATION; SODIUM CHLORIDE; SYNAPTOPHYSIN;

EID: 84874476189     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.748919     Document Type: Article

References (40)

1. Senior K. US report draws attention to preventable vision problems. Lancet 2002;359(9312):1129.
2. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:283-290. (Pubitemid 36351495)
3. Dandona P, Thusu K, Cook S, Snyder, B, Makowski, J, Armstrong, D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-445. (Pubitemid 26054071)
4. Zheng L, Du Y, Miller C, Gubitosi-Klug, RA, Ball, S, Berkowitz, BA, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 2007;50:1987-1996. (Pubitemid 47222853)
5. Rivero A, Mora C, Muros M, Garcia, J, Herrera, H, Navarro-Gonzalez, JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond) 2009;116:479-492.
6. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446-1454.
7. Zheng Z, Chen H, Ke G, Fan, Y, Zou, H, Sun, X, et al. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway. Diabetes 2009;58:954-964.
8. Fletcher EL, Phipps JA, Ward MM, Puthussery, T, Wilkinson-Berka, JL. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 2007;13:2699-2712. (Pubitemid 47423662)
9. Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004;45:1002-1008. (Pubitemid 38868404)
10. Kurihara T, Ozawa Y, Nagai N, Shinoda, K, Noda, K, Imamura, Y, et al. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008;57:2191-2198.
11. Barber AJ, Lieth E, Khin SA, Antonetti, DA, Buchanan, AG, Gardner, TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-791. (Pubitemid 28399611)
12. Ali TK, Matragoon S, Pillai BA, Liou, GI, El-Remessy, AB. Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 2008;57:889-898.
13. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008;586:4401-4408.
14. Seki M, Tanaka T, Nawa H, Usui, T, Fukuchi, T, Ikeda, K, et al. Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neuro-trophic factor for dopaminergic amacrine cells. Diabetes 2004;53:2412-2419. (Pubitemid 39145597)
15. Hong Y, Chen S, Zhang JM. Hydrogen as a selective antioxidant: a review of clinical and experimental studies. J Int Med Re 2010;38(6):1893-1903.
16. Fukuda K, Asoh S, Ishikawa M, Yamamoto, Y, Ohsawa, I, Ohta, S. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun 2007;361:670-674. (Pubitemid 47238041)
17. Ohsawa I, Ishikawa M, Takahashi K, Watanabe, M, Nishimaki, K, Yamagata, K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007;13:688-694. (Pubitemid 46889750)
18. Hayashida K, Sano M, Ohsawa I, Shinmura, K, Tamaki, K, Endo, J, et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2008;373:30-35.
19. Huang CS, Kawamura T, Toyoda Y, Nakao, A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res 2010;44(9):971-982.
20. Oharazawa H, Igarashi T, Yokota T, Fujii, H, Suzuki, H, Machide, M, et al. Protection of the retina by rapid diffusion of hydrogen: administration of hydrogen-loaded eye drops in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2010;51(1):487-492.
21. Wei L, Ge L, Qin S, Shi, Y, Du, C, Du, H, et al. Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig. Exp Eye Res 2012;94(1): 117-127.
22. Junk AK, Mammis A, Savitz SI, Singh, M, Roth, S, Malhotra, S, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci 2002;99(16):10659-10664.
23. Hotta N, Koh N, Sakakibara F, Nakamura, J, Hamada, Y, Naruse, K, et al. Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. Exp Physiol 1995;80(6):981-989.
24. Wurziger K, Lichtenberger T, Hanitzsch R. On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vision Res 2001;41(8): 1091-1101. (Pubitemid 32285382)
25. Tzekov R, Arden GB. The electroretinogram in diabetic retinopathy. Surv Ophthalmol 1999;44:53-60. (Pubitemid 29378353)
26. Algvere P. Clinical studies on the oscillatory potentials of the human electroretinogram with special reference to the scotopic b-wave. Acta Ophthalmol (Copenh) 1968;46(5): 993-1024.
27. Yonemura D, Kawasaki K. New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential. Doc Ophthalmol 1979;48:163-222. (Pubitemid 10146549)
28. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008; 9(4):315-327.
29. Yamagishi S, Matsui T. Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. Curr Pharm Biotechnol 2011;12(3):362-368.
30. Zhou T, Zhou KK, Lee K, Gao, G, Lyons, TJ, Kowluru, R, et al. The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy. Diabetologia 2011;54(2):459-468.
31. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50: 1938-1942. (Pubitemid 33641616)
32. Haskins K, Bradley B, Powers K, Fadok, V, Flores, S, Ling, X, et al. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003;1005:43-54. (Pubitemid 38507733)
33. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603.
34. Spiwoks-Becker I, Vollrath L, Seeliger MW, Jaissle, G, Eshkind, LG, Leube, RE, et al. Synaptic vesicle alterations in rod photoreceptors of synaptophysin-deficient mice. Neuroscience 2001;107:127-142. (Pubitemid 34020691)
35. Dudek H, Datta SR, Franke TF, Robinson, AC, Tournier, C. Regulation of neuronal survival by the serine-threonine protein kinase. Akt Sci 1997;275(5300):661-665. (Pubitemid 27061332)
36. Ikegami K, Koike T. Membrane depolarization-mediated survival of sympathetic neurons occurs through both phosphatidylinositol 3-kinase-and CaM kinase II-depen-dent pathways. Brain Res 2000;866:218-226. (Pubitemid 30313024)
37. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004;22:123-131. (Pubitemid 39377904)
38. Lohof AM, Ip NY, Poo MM. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993;363:350-353. (Pubitemid 23161530)
39. Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res 1984;3:223-227. (Pubitemid 14163881)
40. Ali TK, El-Remessy AB. Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy 2009;29(2):182-192.